Login / Signup

NEJM at ESMO - Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer.

Eric J RubinOladapo O YekuStephen Morrissey
Published in: The New England journal of medicine (2024)
Keyphrases
  • early stage
  • advanced non small cell lung cancer
  • sentinel lymph node
  • free survival
  • squamous cell carcinoma
  • radiation therapy
  • rectal cancer